Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. (August 2015)

Record Type:: Journal Article
Title:: Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. (August 2015)
Main Title:: Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315
Authors:: Bicakli, Derya Hopanci
Varol, Umut
Degirmenci, Mustafa
Tunali, Didem
Cakar, Burcu
Durusoy, Raika
Karaca, Burcak
Sanli, Ulus Ali
Uslu, Ruchan
Abstract:
Is Part Of:: Journal of oncology pharmacy practice. Volume 21:Number 4(2015:Dec.)
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 21:Number 4(2015:Dec.)
Issue Display:: Volume 21, Issue 4 (2015)
Year:: 2015
Volume:: 21
Issue:: 4
Issue Sort Value:: 2015-0021-0004-0000
Page Start:: 318
Page End:: 319
Publication Date:: 2015-08
Subjects:: Cancer -- Chemotherapy -- Periodicals
Clinical pharmacology -- Periodicals
616.994061
Journal URLs:: http://opp.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗
DOI:: 10.1177/1078155215585051 ↗
Languages:: English
ISSNs:: 1078-1552
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 6817.xml